Lidocaine 2% With Adrenaline Generics bulk supplier for pharma manufacturers

Lidocaine 2% With Adrenaline Generics Suppliers & Bulk Manufacturers

Available Forms: Sterile injection solution

Available Strengths: Lidocaine HCl 2% (20 mg/mL), Adrenaline (Epinephrine): 1:200,000 (5 mcg/mL), 1:100,000 (10 mcg/mL)

Reference Brands: Xylocaine® with Epinephrine (US), Lignospan® (EU)

Category: Anaesthetics

Lidocaine 2% With Adrenaline Generics is available in Sterile injection solution and strengths such as Lidocaine HCl 2% (20 mg/mL), Adrenaline (Epinephrine): 1:200,000 (5 mcg/mL), 1:100,000 (10 mcg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lidocaine 2% With Adrenaline Generics is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Lidocaine 2% With Adrenaline Generics can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Lidocaine 2% with Adrenaline is a widely used local anesthetic solution combining 20 mg/mL of Lidocaine HCl with epinephrine (1:100,000 or 1:200,000) to provide extended anesthesia and reduced bleeding during surgical, dental, and minor procedures. The vasoconstrictive effect of adrenaline prolongs lidocaine’s action and enhances procedural safety. Available in sterile single- or multi-dose vials and dental cartridges, this product is approved in both the US (FDA) and EU (EMA) under brands like Xylocaine®, Lignospan®, and Septanest®. It is ideal for pharma B2B partners, tenders, and hospital procurement across regulated global markets.

Frequently Asked Questions

Yes, Lidocaine 2% With Adrenaline Generics is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Lidocaine 2% With Adrenaline Generics is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Tetracaine Hcl And Generics

Strength: 1%

Form: injection

Reference Brands:

View Details
Tetracaine Hcl And Generics

Strength: 1%

Form: injection

Reference Brands:

View Details
Procaine Generics

Strength: 0.5%, 1%, 2% and 10%

Form: Injection

Reference Brands: Novocain, Procainum(EU & US)

View Details
Articaine

Strength: 4% Articaine + Epinephrine 1:100,000 or 1:200,000

Form: Injectable (cartridge/vial)

Reference Brands: Septanest®(EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.